Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-25 @ 2:50 AM
NCT ID:
NCT06529133
Eligibility Criteria:
For the study group:
Inclusion Criteria:
1. Being between the ages of 7-16
2. Having been diagnosed with epilepsy
3. Having had a seizure in the last 2 years
4. Being on antiepileptic medication
5. Having a body mass index within normal limits (18.5-24.9 kg/m2)
Exclusion Criteria:
1. Being hypermobile (Beighton score \>5 and above)
2. Leg length inequality
3. Having any neurological, rheumatic, musculoskeletal, metabolic and connective tissue disease
4. Pain, deformity or surgical history related to the vertebral column and lower extremity
5. Presence of cognitive, mental and/or serious psychiatric disease
6. Participating in any exercise program or sporting activity in the last six months
7. Hearing and/or vision loss
For the control group:
Inclusion Criteria:
1. Being between the ages of 7-16
2. Having a body mass index within normal limits (18.5-24.9 kg/m2)
Exclusion Criteria:
1. Being hypermobile (Beighton score \>5 and above)
2. Leg length inequality
3. Having any neurological, rheumatic, musculoskeletal, metabolic and connective tissue disease
4. Pain, deformity or surgical history related to the vertebral column and lower extremity
5. Presence of cognitive, mental and/or serious psychiatric disease
6. Participating in any exercise program or sporting activity in the last six months
7. Hearing and/or vision loss
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
7 Years
Maximum Age:
16 Years
Study:
NCT06529133
Study Brief:
Protocol Section:
NCT06529133